Epidemiology of pediatric surgical admissions in US children: data from the HCUP kids inpatient database

Keane Y S Tzong1, Sena Han, Arthur Roh

  • 1Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.

Insights

Approximately 450,000 children undergo inpatient surgery annually in the U.S. This includes 115,000 children under age 3, highlighting potential anesthesia exposure risks for vulnerable pediatric populations.

Area of Science:

  • Pediatric Anesthesia
  • Neurodevelopmental Toxicology
  • Healthcare Utilization

Background:

  • Developing brains in children are susceptible to anesthetic neurotoxicity.
  • Concerns exist regarding long-term neurological effects of early-life anesthesia exposure.
  • National data on pediatric surgical procedures are needed to assess exposure scope.

Purpose of the Study:

  • To estimate the annual frequency of inpatient surgical procedures in U.S. children.
  • To identify the types of surgeries and age groups most affected.
  • To inform the understanding of potential anesthesia exposure in pediatric populations.

Main Methods:

  • Utilized the Kids' Inpatient Database (KID) for 2003, 2006, and 2009.
  • Analyzed demographic variables and procedure categories for pediatric discharges.
  • Calculated rates and types of inpatient surgeries in children.

Main Results:

  • An estimated 450,000 pediatric inpatient surgical admissions occurred annually.
  • 115,000 admissions annually were for children under 3 years old.
  • Gastrointestinal, orthopedic, and urological surgeries comprised 55% of pediatric surgical admissions.

Conclusions:

  • Around 450,000 U.S. children under 18 are admitted annually for inpatient surgery.
  • A quarter of these pediatric surgical patients are under 3 years old.
  • Findings are crucial for evaluating anesthesia exposure in young children, especially when combined with ambulatory surgery data.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...